BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB. Omega-3 Fatty Acid-Derived Mediators 17( R )-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice. J I 2011;187:1957-69. [DOI: 10.4049/jimmunol.1101305] [Cited by in Crossref: 168] [Cited by in F6Publishing: 163] [Article Influence: 15.3] [Reference Citation Analysis]
Number Citing Articles
1 Vargas Robles H, Citalán Madrid AF, García Ponce A, Silva Olivares A, Shibayama M, Betanzos A, Del Valle Mondragón L, Nava P, Schnoor M. Experimental Colitis Is Attenuated by Cardioprotective Diet Supplementation That Reduces Oxidative Stress, Inflammation, and Mucosal Damage. Oxid Med Cell Longev 2016;2016:8473242. [PMID: 26881044 DOI: 10.1155/2016/8473242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
2 Keeren K, Huang D, Smyl C, Fischer A, Rothe M, Weylandt KH. Effect of Different Omega-6/Omega-3 Polyunsaturated Fatty Acid Ratios on the Formation of Monohydroxylated Fatty Acids in THP-1 Derived Macrophages. Biology (Basel) 2015;4:314-26. [PMID: 25860776 DOI: 10.3390/biology4020314] [Reference Citation Analysis]
3 Chiu CY, Gomolka B, Dierkes C, Huang NR, Schroeder M, Purschke M, Manstein D, Dangi B, Weylandt KH. Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis. Inflamm Res. 2012;61:967-976. [PMID: 22618200 DOI: 10.1007/s00011-012-0489-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
4 Schmid M, Gemperle C, Rimann N, Hersberger M. Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32. J Immunol 2016;196:3429-37. [PMID: 26969756 DOI: 10.4049/jimmunol.1501701] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
5 Shevalye H, Yorek MS, Coppey LJ, Holmes A, Harper MM, Kardon RH, Yorek MA. Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes. J Neurophysiol 2015;114:199-208. [PMID: 25925322 DOI: 10.1152/jn.00224.2015] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
6 Recchiuti A. Resolvin D1 and its GPCRs in resolution circuits of inflammation. Prostaglandins & Other Lipid Mediators 2013;107:64-76. [DOI: 10.1016/j.prostaglandins.2013.02.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
7 Chee B, Park B, Fitzsimmons T, Coates AM, Bartold PM. Omega-3 fatty acids as an adjunct for periodontal therapy-a review. Clin Oral Investig 2016;20:879-94. [PMID: 26885664 DOI: 10.1007/s00784-016-1750-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
8 Avila-Román J, Talero E, Alcaide A, Reyes Cde L, Zubía E, García-Mauriño S, Motilva V. Preventive effect of the microalga Chlamydomonas debaryana on the acute phase of experimental colitis in rats. Br J Nutr 2014;112:1055-64. [PMID: 25192306 DOI: 10.1017/S0007114514001895] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Katz MS, Thatch KA, Schwartz MZ. Gene alterations and intestinal mucosal changes following growth factor and omega-3 exposure in a rat model of inflammatory bowel disease. J Pediatr Surg 2013;48:345-52. [PMID: 23414863 DOI: 10.1016/j.jpedsurg.2012.11.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Dubé L, Spahis S, Lachaîne K, Lemieux A, Monhem H, Poulin S, Randoll C, Travaillaud E, Ould-chikh N, Marcil V, Delvin E, Levy E. SPECIALIZED PRO-RESOLVING MEDIATORS DERIVED FROM N-3 POLYUNSATURATED FATTY ACIDS: ROLE IN METABOLIC SYNDROME AND RELATED COMPLICATIONS. Antioxidants & Redox Signaling. [DOI: 10.1089/ars.2021.0156] [Reference Citation Analysis]
11 Yang M, Bair JA, Hodges RR, Serhan CN, Dartt DA. Resolvin E1 Reduces Leukotriene B4-Induced Intracellular Calcium Increase and Mucin Secretion in Rat Conjunctival Goblet Cells. Am J Pathol 2020;190:1823-32. [PMID: 32561135 DOI: 10.1016/j.ajpath.2020.06.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Li C, Wu X, Liu S, Shen D, Zhu J, Liu K. Role of Resolvins in the Inflammatory Resolution of Neurological Diseases. Front Pharmacol 2020;11:612. [PMID: 32457616 DOI: 10.3389/fphar.2020.00612] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
13 Sun J, Zhang H, Liu F, Tang D, Lu X. Ameliorative effects of aspirin against lipopolysaccharide-induced preeclampsia-like symptoms in rats by inhibiting the pro-inflammatory pathway. Can J Physiol Pharmacol 2018;96:1084-91. [DOI: 10.1139/cjpp-2018-0087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Alhouayek M, Ameraoui H, Muccioli GG. Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158854. [PMID: 33157277 DOI: 10.1016/j.bbalip.2020.158854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhao Y, Ma T, Zhang Z, Chen X, Zhou C, Zhang L, Zou D. Resolvin D1 attenuates acid-induced DNA damage in esophageal epithelial cells and rat models of acid reflux. Eur J Pharmacol 2021;912:174571. [PMID: 34656605 DOI: 10.1016/j.ejphar.2021.174571] [Reference Citation Analysis]
16 Lee HN, Choi YS, Kim SH, Zhong X, Kim W, Park JS, Saeidi S, Han BW, Kim N, Lee HS, Choi YJ, Baek JH, Na HK, Surh YJ. Resolvin D1 suppresses inflammation-associated tumorigenesis in the colon by inhibiting IL-6-induced mitotic spindle abnormality. FASEB J 2021;35:e21432. [PMID: 33794029 DOI: 10.1096/fj.202002392R] [Reference Citation Analysis]
17 Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 2016;16:51-67. [PMID: 26688348 DOI: 10.1038/nri.2015.4] [Cited by in Crossref: 250] [Cited by in F6Publishing: 239] [Article Influence: 35.7] [Reference Citation Analysis]
18 Generoso Sde V, Rodrigues NM, Trindade LM, Paiva NC, Cardoso VN, Carneiro CM, Ferreira AV, Faria AM, Maioli TU. Dietary supplementation with omega-3 fatty acid attenuates 5-fluorouracil induced mucositis in mice. Lipids Health Dis 2015;14:54. [PMID: 26063053 DOI: 10.1186/s12944-015-0052-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
19 Lance KD, Chatterjee A, Wu B, Mottola G, Nuhn H, Lee PP, Sansbury BE, Spite M, Desai TA, Conte MS. Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device. J Biomed Mater Res A 2017;105:31-41. [PMID: 27508346 DOI: 10.1002/jbm.a.35861] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
20 Masterson JC, McNamee EN, Fillon SA, Hosford L, Harris R, Fernando SD, Jedlicka P, Iwamoto R, Jacobsen E, Protheroe C, Eltzschig HK, Colgan SP, Arita M, Lee JJ, Furuta GT. Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis. Gut 2015;64:1236-47. [PMID: 25209655 DOI: 10.1136/gutjnl-2014-306998] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 9.0] [Reference Citation Analysis]
21 Kooij G, Troletti CD, Leuti A, Norris PC, Riley I, Albanese M, Ruggieri S, Libreros S, van der Pol SMA, van Het Hof B, Schell Y, Guerrera G, Buttari F, Mercuri NB, Centonze D, Gasperini C, Battistini L, de Vries HE, Serhan CN, Chiurchiù V. Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction. Haematologica 2020;105:2056-70. [PMID: 31780628 DOI: 10.3324/haematol.2019.219519] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
22 Kikut J, Drozd A, Mokrzycka M, Grzybowska-chlebowczyk U, Ziętek M, Szczuko M. Are EPA and DHA Derivatives Involved in IBD Remission? JCM 2022;11:2388. [DOI: 10.3390/jcm11092388] [Reference Citation Analysis]
23 Easley JT, Nelson JW, Mellas RE, Sommakia S, Wu C, Trump B, Baker OJ. Aspirin-Triggered Resolvin D1 Versus Dexamethasone in the Treatment of Sjögren's Syndrome-Like NOD/ShiLtJ Mice - A Pilot Study. J Rheum Dis Treat 2015;1:027. [PMID: 27110599 DOI: 10.23937/2469-5726/1510027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
24 Jacob SP, Lakshmikanth CL, Chaithra VH, Kumari TR, Chen CH, McIntyre TM, Marathe GK. Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-Tolerance. PLoS One 2016;11:e0153282. [PMID: 27064683 DOI: 10.1371/journal.pone.0153282] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
25 Campbell EL, Serhan CN, Colgan SP. Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators. J Immunol 2011;187:3475-81. [PMID: 21934099 DOI: 10.4049/jimmunol.1100150] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
26 Camba-Gómez M, Gualillo O, Conde-Aranda J. New Perspectives in the Study of Intestinal Inflammation: Focus on the Resolution of Inflammation. Int J Mol Sci 2021;22:2605. [PMID: 33807591 DOI: 10.3390/ijms22052605] [Reference Citation Analysis]
27 Colby JK, Jaoude J, Liu F, Shureiqi I. Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer. Cancer Metastasis Rev 2018;37:289-315. [DOI: 10.1007/s10555-018-9743-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
28 Ungaro F, Tacconi C, Massimino L, Corsetto PA, Correale C, Fonteyne P, Piontini A, Garzarelli V, Calcaterra F, Della Bella S, Spinelli A, Carvello M, Rizzo AM, Vetrano S, Petti L, Fiorino G, Furfaro F, Mavilio D, Maddipati KR, Malesci A, Peyrin-Biroulet L, D'Alessio S, Danese S. MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice. Gastroenterology 2017;153:1363-1377.e6. [PMID: 28827082 DOI: 10.1053/j.gastro.2017.07.048] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
29 Zhao Q, Wu J, Lin Z, Hua Q, Zhang W, Ye L, Wu G, Du J, Xia J, Chu M, Hu X. Resolvin D1 Alleviates the Lung Ischemia Reperfusion Injury via Complement, Immunoglobulin, TLR4, and Inflammatory Factors in Rats. Inflammation 2016;39:1319-33. [PMID: 27145782 DOI: 10.1007/s10753-016-0364-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
30 Zahoor I, Giri S. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis. Clin Rev Allergy Immunol 2021;60:147-63. [PMID: 32495237 DOI: 10.1007/s12016-020-08796-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Ramiro-Cortijo D, Singh P, Liu Y, Medina-Morales E, Yakah W, Freedman SD, Martin CR. Breast Milk Lipids and Fatty Acids in Regulating Neonatal Intestinal Development and Protecting against Intestinal Injury. Nutrients 2020;12:E534. [PMID: 32092925 DOI: 10.3390/nu12020534] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
32 Li D, Hodges RR, Jiao J, Carozza RB, Shatos MA, Chiang N, Serhan CN, Dartt DA. Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion. Mucosal Immunol 2013;6:1119-30. [PMID: 23462912 DOI: 10.1038/mi.2013.7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
33 Yates CM, Calder PC, Ed Rainger G. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacology & Therapeutics 2014;141:272-82. [DOI: 10.1016/j.pharmthera.2013.10.010] [Cited by in Crossref: 212] [Cited by in F6Publishing: 188] [Article Influence: 26.5] [Reference Citation Analysis]
34 Caprara G. Mediterranean-Type Dietary Pattern and Physical Activity: The Winning Combination to Counteract the Rising Burden of Non-Communicable Diseases (NCDs). Nutrients 2021;13:429. [PMID: 33525638 DOI: 10.3390/nu13020429] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
35 Weylandt KH, Serini S, Chen YQ, Su HM, Lim K, Cittadini A, Calviello G. Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence. Biomed Res Int 2015;2015:143109. [PMID: 26301240 DOI: 10.1155/2015/143109] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
36 Ho GT, Cartwright JA, Thompson EJ, Bain CC, Rossi AG. Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing. Inflamm Bowel Dis 2020;26:1131-43. [PMID: 32232386 DOI: 10.1093/ibd/izaa045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
37 Castilla-madrigal R, Gil-iturbe E, López de Calle M, Moreno-aliaga MJ, Lostao MP. DHA and its derived lipid mediators MaR1, RvD1 and RvD2 block TNF-α inhibition of intestinal sugar and glutamine uptake in Caco-2 cells. The Journal of Nutritional Biochemistry 2020;76:108264. [DOI: 10.1016/j.jnutbio.2019.108264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
38 Livshits G, Kalinkovich A. Specialized, pro-resolving mediators as potential therapeutic agents for alleviating fibromyalgia symptomatology. Pain Med 2021:pnab060. [PMID: 33565588 DOI: 10.1093/pm/pnab060] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Hu X, Liang Y, Zhao H, Zhao M. Effects of AT-RvD1 on paraquat-induced acute renal injury in mice. International Immunopharmacology 2019;67:231-8. [DOI: 10.1016/j.intimp.2018.12.029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
40 Onali S, Favale A, Fantini MC. The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective. Cells 2019;8:E344. [PMID: 30979024 DOI: 10.3390/cells8040344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
41 Adjouzem CF, Gilbert A, Mbiantcha M, Yousseu Nana W, Matah Marthe Mba V, Djuichou Nguemnang SF, Tsafack EG, Atsamo AD. Effects of Aqueous and Methanolic Extracts of Stem Bark of Alstonia boonei De Wild. (Apocynaceae) on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Wistar Rats. Evid Based Complement Alternat Med 2020;2020:4918453. [PMID: 32565862 DOI: 10.1155/2020/4918453] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
42 Lee Y, Choo J, Kim SJ, Heo G, Pothoulakis C, Kim YH, Im E. Analysis of endogenous lipids during intestinal wound healing. PLoS One 2017;12:e0183028. [PMID: 28800645 DOI: 10.1371/journal.pone.0183028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
43 Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol Aspects Med 2017;58:1-11. [PMID: 28263773 DOI: 10.1016/j.mam.2017.03.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 20.6] [Reference Citation Analysis]
44 Becker F, Romero E, Goetzmann J, Hasselschwert DL, Dray B, Vanchiere J, Fontenot J, Yun JW, Norris PC, White L, Musso M, Serhan CN, Alexander JS, Gavins FNE. Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys. Am J Pathol 2019;189:1953-72. [PMID: 31547920 DOI: 10.1016/j.ajpath.2019.05.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
45 Ostermann AI, Willenberg I, Weylandt KH, Schebb NH. Development of an Online-SPE–LC–MS/MS Method for 26 Hydroxylated Polyunsaturated Fatty Acids as Rapid Targeted Metabolomics Approach for the LOX, CYP, and Autoxidation Pathways of the Arachidonic Acid Cascade. Chromatographia 2015;78:415-28. [DOI: 10.1007/s10337-014-2768-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
46 Chatterjee D, Chatterjee A, Kalra D, Kapoor A, Vijay S, Jain S. Role of adjunct use of omega 3 fatty acids in periodontal therapy of periodontitis. A systematic review and meta-analysis. J Oral Biol Craniofac Res 2022;12:55-62. [PMID: 34760614 DOI: 10.1016/j.jobcr.2021.10.005] [Reference Citation Analysis]
47 Serhan CN, Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol 2013;13:632-40. [PMID: 23747022 DOI: 10.1016/j.coph.2013.05.012] [Cited by in Crossref: 201] [Cited by in F6Publishing: 190] [Article Influence: 22.3] [Reference Citation Analysis]
48 Ungaro F, Rubbino F, Danese S, D'Alessio S. Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases. Front Immunol 2017;8:1331. [PMID: 29109724 DOI: 10.3389/fimmu.2017.01331] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
49 Chiu CY, Smyl C, Dogan I, Rothe M, Weylandt KH. Quantitative Profiling of Hydroxy Lipid Metabolites in Mouse Organs Reveals Distinct Lipidomic Profiles and Modifications Due to Elevated n-3 Fatty Acid Levels. Biology (Basel) 2017;6:E9. [PMID: 28165385 DOI: 10.3390/biology6010009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 Homann J, Suo J, Schmidt M, de Bruin N, Scholich K, Geisslinger G, Ferreirós N. In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse. PLoS One 2015;10:e0143141. [PMID: 26599340 DOI: 10.1371/journal.pone.0143141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
51 Quirós M, Nusrat A. Contribution of Wound-Associated Cells and Mediators in Orchestrating Gastrointestinal Mucosal Wound Repair. Annu Rev Physiol 2019;81:189-209. [PMID: 30354933 DOI: 10.1146/annurev-physiol-020518-114504] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
52 Perna E, Aguilera-Lizarraga J, Florens MV, Jain P, Theofanous SA, Hanning N, De Man JG, Berg M, De Winter B, Alpizar YA, Talavera K, Vanden Berghe P, Wouters M, Boeckxstaens G. Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS. Gut. 2020 epub ahead of print. [PMID: 33023902 DOI: 10.1136/gutjnl-2020-321530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Hong H, Song HK, Hwang ES, Lee AR, Han DS, Kim SE, Oh ES. Up-regulation of syndecan-2 in proximal colon correlates with acute inflammation. FASEB J 2019;33:11381-95. [PMID: 31311305 DOI: 10.1096/fj.201900561R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Dalli J, Serhan C. Macrophage Proresolving Mediators-the When and Where. Microbiol Spectr 2016;4. [PMID: 27337457 DOI: 10.1128/microbiolspec.MCHD-0001-2014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
55 Wang W, Zhu J, Lyu F, Panigrahy D, Ferrara KW, Hammock B, Zhang G. ω-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer. Prostaglandins Other Lipid Mediat. 2014;113-115:13-20. [PMID: 25019221 DOI: 10.1016/j.prostaglandins.2014.07.002] [Cited by in Crossref: 88] [Cited by in F6Publishing: 75] [Article Influence: 11.0] [Reference Citation Analysis]
56 Landa-Juárez AY, Pérez-Severiano F, Castañeda-Hernández G, Ortiz MI, Chávez-Piña AE. The antihyperalgesic effect of docosahexaenoic acid in streptozotocin-induced neuropathic pain in the rat involves the opioidergic system. Eur J Pharmacol 2019;845:32-9. [PMID: 30582909 DOI: 10.1016/j.ejphar.2018.12.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Stopka-farooqui U, Haworth O. Proresolving mediators: new therapies to treat inflammatory diseases. Clinical Lipidology 2015;10:343-50. [DOI: 10.2217/clp.15.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Weylandt KH. Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell. Eur J Pharmacol 2016;785:108-15. [PMID: 26546723 DOI: 10.1016/j.ejphar.2015.11.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
59 Schirmer B, Rezniczek T, Seifert R, Neumann D. Proinflammatory role of the histamine H4 receptor in dextrane sodium sulfate-induced acute colitis. Biochem Pharmacol 2015;98:102-9. [PMID: 26365468 DOI: 10.1016/j.bcp.2015.09.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
60 Weylandt KH, Chiu C, Gomolka B, Waechter SF, Wiedenmann B. Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation. Prostaglandins & Other Lipid Mediators 2012;97:73-82. [DOI: 10.1016/j.prostaglandins.2012.01.005] [Cited by in Crossref: 173] [Cited by in F6Publishing: 156] [Article Influence: 17.3] [Reference Citation Analysis]
61 Lee H, Surh Y. Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders. Biochemical Pharmacology 2012;84:1340-50. [DOI: 10.1016/j.bcp.2012.08.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
62 Quiros M, Nusrat A. Saving Problematic Mucosae: SPMs in Intestinal Mucosal Inflammation and Repair. Trends Mol Med 2019;25:124-35. [PMID: 30642681 DOI: 10.1016/j.molmed.2018.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
63 Lee HJ, Park MK, Lee EJ, Lee CH. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. Int J Biochem Cell Biol. 2013;45:2801-2807. [PMID: 24120851 DOI: 10.1016/j.biocel.2013.09.018] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 6.1] [Reference Citation Analysis]
64 Villaldama-Soriano MA, Rodríguez-Cruz M, Hernández-De la Cruz SY, Almeida-Becerril T, Cárdenas-Conejo A, Wong-Baeza C. Pro-inflammatory monocytes are increased in Duchenne muscular dystrophy and suppressed with omega-3 fatty acids: A double-blind, randomized, placebo-controlled pilot study. Eur J Neurol 2021. [PMID: 34779542 DOI: 10.1111/ene.15184] [Reference Citation Analysis]
65 Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, Fitzgerald JM, Serhan CN, Conte MS. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J. 2013;27:2220-2232. [PMID: 23407709 DOI: 10.1096/fj.12-225615] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 8.6] [Reference Citation Analysis]
66 Giacobbe J, Benoiton B, Zunszain P, Pariante CM, Borsini A. The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders. Front Psychiatry 2020;11:122. [PMID: 32180741 DOI: 10.3389/fpsyt.2020.00122] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
67 Wang Q, Zheng X, Cheng Y, Zhang YL, Wen HX, Tao Z, Li H, Hao Y, Gao Y, Yang LM, Smith FG, Huang CJ, Jin SW. Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na,K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury. J Immunol 2014;192:3765-77. [PMID: 24646745 DOI: 10.4049/jimmunol.1302421] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 7.8] [Reference Citation Analysis]
68 Kalish BT, Fell GL, Nandivada P, Puder M. Clinically Relevant Mechanisms of Lipid Synthesis, Transport, and Storage. JPEN J Parenter Enteral Nutr 2015;39:8S-17S. [PMID: 26187937 DOI: 10.1177/0148607115595974] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
69 Perucci LO, Sugimoto MA, Gomes KB, Dusse LM, Teixeira MM, Sousa LP. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases. Expert Opin Ther Targets 2017;21:879-96. [PMID: 28786708 DOI: 10.1080/14728222.2017.1364363] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
70 Kroschwald S, Chiu CY, Heydeck D, Rohwer N, Gehring T, Seifert U, Lux A, Rothe M, Weylandt KH, Kuhn H. Female mice carrying a defective Alox15 gene are protected from experimental colitis via sustained maintenance of the intestinal epithelial barrier function. Biochim Biophys Acta Mol Cell Biol Lipids 2018;1863:866-80. [PMID: 29702245 DOI: 10.1016/j.bbalip.2018.04.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
71 Luan H, Wang C, Sun J, Zhao L, Li L, Zhou B, Shao S, Shen X, Xu Y. Resolvin D1 Protects Against Ischemia/Reperfusion-Induced Acute Kidney Injury by Increasing Treg Percentages via the ALX/FPR2 Pathway. Front Physiol 2020;11:285. [PMID: 32317985 DOI: 10.3389/fphys.2020.00285] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
72 Serhan CN, Chiang N, Dalli J. Macrophages and the Entrance of Resolution Phase Lipid Mediators. In: Biswas SK, Mantovani A, editors. Macrophages: Biology and Role in the Pathology of Diseases. New York: Springer; 2014. pp. 287-314. [DOI: 10.1007/978-1-4939-1311-4_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Chiurchiù V, Leuti A, Maccarrone M. Bioactive Lipids and Chronic Inflammation: Managing the Fire Within. Front Immunol 2018;9:38. [PMID: 29434586 DOI: 10.3389/fimmu.2018.00038] [Cited by in Crossref: 140] [Cited by in F6Publishing: 127] [Article Influence: 35.0] [Reference Citation Analysis]
74 Carrillo I, Rabelo RAN, Barbosa C, Rates M, Fuentes-Retamal S, González-Herrera F, Guzmán-Rivera D, Quintero H, Kemmerling U, Castillo C, Machado FS, Díaz-Araya G, Maya JD. Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease. PLoS Negl Trop Dis 2021;15:e0009978. [PMID: 34784372 DOI: 10.1371/journal.pntd.0009978] [Reference Citation Analysis]
75 Recchiuti A, Serhan CN. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. Front Immunol. 2012;3:298. [PMID: 23093949 DOI: 10.3389/fimmu.2012.00298] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
76 Wawrzyniak P, Noureddine N, Wawrzyniak M, Lucchinetti E, Krämer SD, Rogler G, Zaugg M, Hersberger M. Nutritional Lipids and Mucosal Inflammation. Mol Nutr Food Res 2021;65:e1901269. [PMID: 32780927 DOI: 10.1002/mnfr.201901269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 See VHL, Mas E, Prescott SL, Beilin LJ, Burrows S, Barden AE, Huang RC, Mori TA. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial. Br J Nutr 2017;118:971-80. [PMID: 29173199 DOI: 10.1017/S0007114517002914] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
78 Marcon R, Bento AF, Dutra RC, Bicca MA, Leite DF, Calixto JB. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis. J Immunol. 2013;191:4288-4298. [PMID: 24038091 DOI: 10.4049/jimmunol.1202743] [Cited by in Crossref: 121] [Cited by in F6Publishing: 123] [Article Influence: 13.4] [Reference Citation Analysis]
79 Inoue Y, Yu YM, Kurihara T, Vasilyev A, Ibrahim A, Oklu R, Zhao G, Nair AV, Brown D, Fischman AJ, Tompkins RG, Irimia D. Kidney and Liver Injuries After Major Burns in Rats Are Prevented by Resolvin D2. Crit Care Med 2016;44:e241-52. [PMID: 26509319 DOI: 10.1097/CCM.0000000000001397] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
80 Sekheri M, El Kebir D, Edner N, Filep JG. 15-Epi-LXA4 and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation. Proc Natl Acad Sci U S A 2020;117:7971-80. [PMID: 32205444 DOI: 10.1073/pnas.1920193117] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
81 Orr SK, Colas RA, Dalli J, Chiang N, Serhan CN. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent. Am J Physiol Lung Cell Mol Physiol 2015;308:L904-11. [PMID: 25770181 DOI: 10.1152/ajplung.00370.2014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
82 Dmitrieva N, Suess G, Shirley R. Resolvins RvD1 and 17(R)-RvD1 alleviate signs of inflammation in a rat model of endometriosis. Fertil Steril 2014;102:1191-6. [PMID: 25123641 DOI: 10.1016/j.fertnstert.2014.06.046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
83 Nagatake T, Kunisawa J. Emerging roles of metabolites of ω3 and ω6 essential fatty acids in the control of intestinal inflammation. Int Immunol 2019;31:569-77. [PMID: 30722032 DOI: 10.1093/intimm/dxy086] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
84 Cordeiro N, Freitas RHCN, Fraga CAM, Fernandes PD. Therapeutic Effects of Anti-Inflammatory N-Acylhydrazones in the Resolution of Experimental Colitis. J Pharmacol Exp Ther 2020;374:420-7. [PMID: 32546529 DOI: 10.1124/jpet.120.000074] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Tu M, Wang W, Zhang G, Hammock BD. ω-3 Polyunsaturated Fatty Acids on Colonic Inflammation and Colon Cancer: Roles of Lipid-Metabolizing Enzymes Involved. Nutrients 2020;12:E3301. [PMID: 33126566 DOI: 10.3390/nu12113301] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Stein K, Stoffels M, Lysson M, Schneiker B, Dewald O, Krönke G, Kalff JC, Wehner S. A role for 12/15-lipoxygenase-derived proresolving mediators in postoperative ileus: protectin DX-regulated neutrophil extravasation. J Leukoc Biol 2016;99:231-9. [PMID: 26292977 DOI: 10.1189/jlb.3HI0515-189R] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
87 Mori TA. Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors. Food Funct 2014;5:2004-19. [DOI: 10.1039/c4fo00393d] [Cited by in Crossref: 44] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
88 Margină D, Ungurianu A, Purdel C, Nițulescu GM, Tsoukalas D, Sarandi E, Thanasoula M, Burykina TI, Tekos F, Buha A, Nikitovic D, Kouretas D, Tsatsakis AM. Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. Food Chem Toxicol 2020;143:111558. [PMID: 32640331 DOI: 10.1016/j.fct.2020.111558] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
89 Sasso O, Migliore M, Habrant D, Armirotti A, Albani C, Summa M, Moreno-Sanz G, Scarpelli R, Piomelli D. Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage. FASEB J 2015;29:2616-27. [PMID: 25757568 DOI: 10.1096/fj.15-270637] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 6.7] [Reference Citation Analysis]
90 Akagi D, Chen M, Toy R, Chatterjee A, Conte MS. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice. FASEB J 2015;29:2504-13. [PMID: 25777995 DOI: 10.1096/fj.14-265363] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 8.6] [Reference Citation Analysis]
91 Krishnamoorthy S, Recchiuti A, Chiang N, Fredman G, Serhan CN. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol 2012;180:2018-27. [PMID: 22449948 DOI: 10.1016/j.ajpath.2012.01.028] [Cited by in Crossref: 164] [Cited by in F6Publishing: 168] [Article Influence: 16.4] [Reference Citation Analysis]
92 Yoo S, Lim JY, Hwang SW. Resolvins: Endogenously-Generated Potent Painkilling Substances and their Therapeutic Perspectives. Curr Neuropharmacol 2013;11:664-76. [PMID: 24396341 DOI: 10.2174/1570159X11311060009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
93 Arnardottir H, Orr SK, Dalli J, Serhan CN. Human milk proresolving mediators stimulate resolution of acute inflammation. Mucosal Immunol 2016;9:757-66. [PMID: 26462421 DOI: 10.1038/mi.2015.99] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 10.4] [Reference Citation Analysis]
94 Poisson LM, Suhail H, Singh J, Datta I, Denic A, Labuzek K, Hoda MN, Shankar A, Kumar A, Cerghet M, Elias S, Mohney RP, Rodriguez M, Rattan R, Mangalam AK, Giri S. Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis. J Biol Chem 2015;290:30697-712. [PMID: 26546682 DOI: 10.1074/jbc.M115.679068] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
95 Erdinest N, Ovadia H, Kormas R, Solomon A. Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study. J Inflamm (Lond) 2014;11:6. [PMID: 24580770 DOI: 10.1186/1476-9255-11-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
96 Zhang H, Wang Q, Mei H, Zheng S, Ali AM, Wu Q, Ye Y, Xu H, Xiang S, Jin S. RvD1 ameliorates LPS-induced acute lung injury via the suppression of neutrophil infiltration by reducing CXCL2 expression and release from resident alveolar macrophages. International Immunopharmacology 2019;76:105877. [DOI: 10.1016/j.intimp.2019.105877] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
97 Murase R, Taketomi Y, Miki Y, Nishito Y, Saito M, Fukami K, Yamamoto K, Murakami M. Group III phospholipase A2 promotes colitis and colorectal cancer. Sci Rep 2017;7:12261. [PMID: 28947740 DOI: 10.1038/s41598-017-12434-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
98 Fishbein A, Hammock BD, Serhan CN, Panigrahy D. Carcinogenesis: Failure of resolution of inflammation? Pharmacol Ther 2021;218:107670. [PMID: 32891711 DOI: 10.1016/j.pharmthera.2020.107670] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
99 Rogler G. Resolution of inflammation in inflammatory bowel disease. Lancet Gastroenterol Hepatol 2017;2:521-30. [PMID: 28606878 DOI: 10.1016/S2468-1253(17)30031-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
100 Livshits G, Kalinkovich A. Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders. Pharmacol Res 2021;164:105340. [PMID: 33276103 DOI: 10.1016/j.phrs.2020.105340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Murata N, Ioi H, Ouchi M, Takao T, Oida H, Aijima R, Yamaza T, Kido M. Effect of Allergen Sensitization on External Root Resorption. J Dent Res 2013;92:641-7. [DOI: 10.1177/0022034513488787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
102 Miranda-Lara CA, Ortiz MI, Rodríguez-Ramos F, Chávez-Piña AE. Synergistic interaction between docosahexaenoic acid and diclofenac on inflammation, nociception, and gastric security models in rats. Drug Dev Res 2018;79:239-46. [PMID: 30188586 DOI: 10.1002/ddr.21438] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
103 Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, Seki K, Aoki-Saito H, Tsurumaki H, Sunaga N, Kaira K, Dobashi K, Yamada M, Okajima F. 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiol Rep 2015;3:e12628. [PMID: 26660549 DOI: 10.14814/phy2.12628] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
104 Qu Q, Xuan W, Fan GH. Roles of resolvins in the resolution of acute inflammation. Cell Biol Int 2015;39:3-22. [PMID: 25052386 DOI: 10.1002/cbin.10345] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
105 Irún P, Lanas A, Piazuelo E. Omega-3 Polyunsaturated Fatty Acids and Their Bioactive Metabolites in Gastrointestinal Malignancies Related to Unresolved Inflammation. A Review. Front Pharmacol 2019;10:852. [PMID: 31427966 DOI: 10.3389/fphar.2019.00852] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
106 Rajasagi NK, Bhela S, Varanasi SK, Rouse BT. Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology. J Leukoc Biol 2017;102:1159-71. [PMID: 28584076 DOI: 10.1189/jlb.3HI1216-511RR] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
107 Murase R, Sato H, Yamamoto K, Ushida A, Nishito Y, Ikeda K, Kobayashi T, Yamamoto T, Taketomi Y, Murakami M. Group X Secreted Phospholipase A2 Releases ω3 Polyunsaturated Fatty Acids, Suppresses Colitis, and Promotes Sperm Fertility. J Biol Chem 2016;291:6895-911. [PMID: 26828067 DOI: 10.1074/jbc.M116.715672] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
108 Wang Q, Yan SF, Hao Y, Jin SW. Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome. Chin Med J (Engl) 2018;131:982-9. [PMID: 29664060 DOI: 10.4103/0366-6999.229890] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
109 Nelson JW, Leigh NJ, Mellas RE, McCall AD, Aguirre A, Baker OJ. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. Am J Physiol Cell Physiol 2014;306:C178-85. [PMID: 24259417 DOI: 10.1152/ajpcell.00284.2013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
110 Huang CH, Hou YC, Pai MH, Yeh CL, Yeh SL. Dietary ω-6/ω-3 Polyunsaturated Fatty Acid Ratios Affect the Homeostasis of Th/Treg Cells in Mice With Dextran Sulfate Sodium-Induced Colitis. JPEN J Parenter Enteral Nutr 2017;41:647-56. [PMID: 27006408 DOI: 10.1177/0148607116638493] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
111 Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol 2000 2013;63:149-64. [PMID: 23931059 DOI: 10.1111/prd.12034] [Cited by in Crossref: 169] [Cited by in F6Publishing: 153] [Article Influence: 24.1] [Reference Citation Analysis]
112 Das UN. Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions. Arch Med Sci 2016;12:1142-57. [PMID: 27695506 DOI: 10.5114/aoms.2016.61918] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
113 Cheifetz AS, Gianotti R, Luber R, Gibson PR. Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases. Gastroenterology. 2017;152:415-429.e15. [PMID: 27743873 DOI: 10.1053/j.gastro.2016.10.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 11.2] [Reference Citation Analysis]
114 Liu R, Li Z, Wang Q. Resolvin D1 Attenuates Myocardial Infarction in a Rodent Model with the Participation of the HMGB1 Pathway. Cardiovasc Drugs Ther 2019;33:399-406. [DOI: 10.1007/s10557-019-06884-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
115 Forner S, Martini A, de Andrade E, Rae G. Neuropathic pain induced by spinal cord injury: Role of endothelin ETA and ETB receptors. Neuroscience Letters 2016;617:14-21. [DOI: 10.1016/j.neulet.2016.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
116 Gu Z, Lamont GJ, Lamont RJ, Uriarte SM, Wang H, Scott DA. Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes. Innate Immun 2016;22:186-95. [PMID: 26878867 DOI: 10.1177/1753425916628618] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
117 Sikka P, Behl T, Sharma S, Sehgal A, Bhatia S, Al-Harrasi A, Singh S, Sharma N, Aleya L. Exploring the therapeutic potential of omega-3 fatty acids in depression. Environ Sci Pollut Res Int 2021;28:43021-34. [PMID: 34121162 DOI: 10.1007/s11356-021-14884-5] [Reference Citation Analysis]
118 Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2015;7:a016311. [PMID: 25359497 DOI: 10.1101/cshperspect.a016311] [Cited by in Crossref: 218] [Cited by in F6Publishing: 208] [Article Influence: 27.3] [Reference Citation Analysis]
119 Kurihara T, Jones CN, Yu YM, Fischman AJ, Watada S, Tompkins RG, Fagan SP, Irimia D. Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J 2013;27:2270-81. [PMID: 23430978 DOI: 10.1096/fj.12-219519] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 6.1] [Reference Citation Analysis]
120 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
121 León IC, Quesada-Vázquez S, Sáinz N, Guruceaga E, Escoté X, Moreno-Aliaga MJ. Effects of Maresin 1 (MaR1) on Colonic Inflammation and Gut Dysbiosis in Diet-Induced Obese Mice. Microorganisms 2020;8:E1156. [PMID: 32751593 DOI: 10.3390/microorganisms8081156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
122 Chiang N, Dalli J, Colas RA, Serhan CN. Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J Exp Med 2015;212:1203-17. [PMID: 26195725 DOI: 10.1084/jem.20150225] [Cited by in Crossref: 200] [Cited by in F6Publishing: 195] [Article Influence: 28.6] [Reference Citation Analysis]
123 Dalli J, Serhan CN. Pro-Resolving Mediators in Regulating and Conferring Macrophage Function. Front Immunol 2017;8:1400. [PMID: 29163481 DOI: 10.3389/fimmu.2017.01400] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
124 Schwanke RC, Marcon R, Bento AF, Calixto JB. EPA- and DHA-derived resolvins' actions in inflammatory bowel disease. Eur J Pharmacol 2016;785:156-64. [PMID: 26325092 DOI: 10.1016/j.ejphar.2015.08.050] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
125 Iordanova Schistad E, Kong XY, Furberg AS, Bäckryd E, Grimnes G, Emaus N, Rosseland LA, Gordh T, Stubhaug A, Engdahl B, Halvorsen B, Nielsen CS. A population-based study of inflammatory mechanisms and pain sensitivity. Pain 2020;161:338-50. [PMID: 31651577 DOI: 10.1097/j.pain.0000000000001731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
126 Lin N, Shay JES, Xie H, Lee DSM, Skuli N, Tang Q, Zhou Z, Azzam A, Meng H, Wang H, FitzGerald GA, Simon MC. Myeloid Cell Hypoxia-Inducible Factors Promote Resolution of Inflammation in Experimental Colitis. Front Immunol 2018;9:2565. [PMID: 30455703 DOI: 10.3389/fimmu.2018.02565] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
127 Ferguson B, Bokka NR, Maddipati KR, Ayilavarapu S, Weltman R, Zhu L, Chen W, Zheng WJ, Angelov N, Van Dyke TE, Lee CT. Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation. Front Immunol 2020;11:1307. [PMID: 32670289 DOI: 10.3389/fimmu.2020.01307] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
128 Dalli J, Winkler JW, Colas RA, Arnardottir H, Cheng CY, Chiang N, Petasis NA, Serhan CN. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem Biol 2013;20:188-201. [PMID: 23438748 DOI: 10.1016/j.chembiol.2012.11.010] [Cited by in Crossref: 145] [Cited by in F6Publishing: 139] [Article Influence: 16.1] [Reference Citation Analysis]
129 Robinson DT, Palac HL, Baillif V, Van Goethem E, Dubourdeau M, Van Horn L, Martin CR. Long chain fatty acids and related pro-inflammatory, specialized pro-resolving lipid mediators and their intermediates in preterm human milk during the first month of lactation. Prostaglandins Leukot Essent Fatty Acids 2017;121:1-6. [PMID: 28651692 DOI: 10.1016/j.plefa.2017.05.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
130 Kalish BT, Le HD, Fitzgerald JM, Wang S, Seamon K, Gura KM, Gronert K, Puder M. Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators. Am J Physiol Gastrointest Liver Physiol 2013;305:G818-28. [PMID: 24091595 DOI: 10.1152/ajpgi.00106.2013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
131 Chiang N, de la Rosa X, Libreros S, Serhan CN. Novel Resolvin D2 Receptor Axis in Infectious Inflammation. J Immunol 2017;198:842-51. [PMID: 27994074 DOI: 10.4049/jimmunol.1601650] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 12.8] [Reference Citation Analysis]
132 Ma C, Vasu R, Zhang H. The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease. Mediators Inflamm 2019;2019:8495913. [PMID: 31780872 DOI: 10.1155/2019/8495913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
133 Cao L, Wang Y, Wang Y, Lv F, Liu L, Li Z. Resolvin D2 suppresses NLRP3 inflammasome by promoting autophagy in macrophages. Exp Ther Med 2021;22:1222. [PMID: 34603519 DOI: 10.3892/etm.2021.10656] [Reference Citation Analysis]
134 Toewe A, Balas L, Durand T, Geisslinger G, Ferreirós N. Simultaneous determination of PUFA-derived pro-resolving metabolites and pathway markers using chiral chromatography and tandem mass spectrometry. Analytica Chimica Acta 2018;1031:185-94. [DOI: 10.1016/j.aca.2018.05.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
135 Duarte LRF, Pinho V, Rezende BM, Teixeira MM. Resolution of Inflammation in Acute Graft-Versus-Host-Disease: Advances and Perspectives. Biomolecules 2022;12:75. [DOI: 10.3390/biom12010075] [Reference Citation Analysis]
136 Biasi F, Leonarduzzi G, Oteiza PI, Poli G. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid Redox Signal. 2013;19:1711-1747. [PMID: 23305298 DOI: 10.1089/ars.2012.4530] [Cited by in Crossref: 118] [Cited by in F6Publishing: 121] [Article Influence: 13.1] [Reference Citation Analysis]
137 Dalli J, Serhan CN. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 2012;120:e60-72. [PMID: 22904297 DOI: 10.1182/blood-2012-04-423525] [Cited by in Crossref: 314] [Cited by in F6Publishing: 307] [Article Influence: 31.4] [Reference Citation Analysis]
138 Rohwer N, Chiu CY, Huang D, Smyl C, Rothe M, Rund KM, Helge Schebb N, Kühn H, Weylandt KH. Omega-3 fatty acids protect from colitis via an Alox15-derived eicosanoid. FASEB J 2021;35:e21491. [PMID: 33710695 DOI: 10.1096/fj.202002340RR] [Reference Citation Analysis]
139 Ibarguren M, López DJ, Escribá PV. The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health. Biochimica et Biophysica Acta (BBA) - Biomembranes 2014;1838:1518-28. [DOI: 10.1016/j.bbamem.2013.12.021] [Cited by in Crossref: 159] [Cited by in F6Publishing: 138] [Article Influence: 19.9] [Reference Citation Analysis]
140 Hamabata T, Nakamura T, Masuko S, Maeda S, Murata T. Production of lipid mediators across different disease stages of dextran sodium sulfate-induced colitis in mice. J Lipid Res 2018;59:586-95. [PMID: 29414763 DOI: 10.1194/jlr.M079095] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
141 Zhao XW, Bao JJ, Hu C, Ding H, Liu XC, Mei Q, Xu JM. Effect of diclofenac on the levels of lipoxin A4 and Resolvin D1 and E1 in the post-ERCP pancreatitis. Dig Dis Sci 2014;59:2992-6. [PMID: 25030943 DOI: 10.1007/s10620-014-3280-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
142 Bhat TA, Kalathil SG, Bogner PN, Lehmann PV, Thatcher TH, Sime PJ, Thanavala Y. AT-RvD1 Mitigates Secondhand Smoke-Exacerbated Pulmonary Inflammation and Restores Secondhand Smoke-Suppressed Antibacterial Immunity. J Immunol 2021;206:1348-60. [PMID: 33558371 DOI: 10.4049/jimmunol.2001228] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
143 Mao F, Wang M, Wang J, Xu W. The role of 15-LOX-1 in colitis and colitis-associated colorectal cancer. Inflamm Res 2015;64:661-9. [DOI: 10.1007/s00011-015-0852-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
144 Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16:531-543. [PMID: 31312042 DOI: 10.1038/s41575-019-0172-4] [Cited by in Crossref: 142] [Cited by in F6Publishing: 141] [Article Influence: 47.3] [Reference Citation Analysis]
145 Cooray SN, Gobbetti T, Montero-Melendez T, McArthur S, Thompson D, Clark AJ, Flower RJ, Perretti M. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc Natl Acad Sci U S A 2013;110:18232-7. [PMID: 24108355 DOI: 10.1073/pnas.1308253110] [Cited by in Crossref: 179] [Cited by in F6Publishing: 173] [Article Influence: 19.9] [Reference Citation Analysis]
146 Barker G, Leeuwenburgh C, Brusko T, Moldawer L, Reddy ST, Guirgis FW. Lipid and Lipoprotein Dysregulation in Sepsis: Clinical and Mechanistic Insights into Chronic Critical Illness. J Clin Med 2021;10:1693. [PMID: 33920038 DOI: 10.3390/jcm10081693] [Reference Citation Analysis]
147 Gabbs M, Leng S, Devassy JG, Monirujjaman M, Aukema HM. Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs. Adv Nutr 2015;6:513-40. [PMID: 26374175 DOI: 10.3945/an.114.007732] [Cited by in Crossref: 267] [Cited by in F6Publishing: 255] [Article Influence: 38.1] [Reference Citation Analysis]
148 Kuzumoto T, Tanigawa T, Higashimori A, Kitamura H, Nadatani Y, Otani K, Fukunaga S, Hosomi S, Tanaka F, Kamata N, Nagami Y, Taira K, Watanabe T, Fujiwara Y. Protective role of resolvin D1, a pro-resolving lipid mediator, in nonsteroidal anti-inflammatory drug-induced small intestinal damage. PLoS One 2021;16:e0250862. [PMID: 33945545 DOI: 10.1371/journal.pone.0250862] [Reference Citation Analysis]
149 Morin C, Blier PU, Fortin S. MAG-EPA reduces severity of DSS-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol 2016;310:G808-21. [PMID: 27012773 DOI: 10.1152/ajpgi.00136.2015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
150 Bento AF, Leite DF, Marcon R, Claudino RF, Dutra RC, Cola M, Martini AC, Calixto JB. Evaluation of chemical mediators and cellular response during acute and chronic gut inflammatory response induced by dextran sodium sulfate in mice. Biochem Pharmacol. 2012;84:1459-1469. [PMID: 23000912 DOI: 10.1016/j.bcp.2012.09.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
151 Obrosov A, Coppey LJ, Shevalye H, Yorek MA. Effect of Fish Oil vs. Resolvin D1, E1, Methyl Esters of Resolvins D1 or D2 on Diabetic Peripheral Neuropathy. J Neurol Neurophysiol 2017;8:453. [PMID: 29423332 DOI: 10.4172/2155-9562.1000453] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
152 Maria-Ferreira D, Nascimento AM, Cipriani TR, Santana-Filho AP, Watanabe PDS, Sant Ana DMG, Luciano FB, Bocate KCP, van den Wijngaard RM, Werner MFP, Baggio CH. Rhamnogalacturonan, a chemically-defined polysaccharide, improves intestinal barrier function in DSS-induced colitis in mice and human Caco-2 cells. Sci Rep 2018;8:12261. [PMID: 30115942 DOI: 10.1038/s41598-018-30526-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
153 Eickmeier O, Seki H, Haworth O, Hilberath JN, Gao F, Uddin M, Croze RH, Carlo T, Pfeffer MA, Levy BD. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. Mucosal Immunol 2013;6:256-66. [PMID: 22785226 DOI: 10.1038/mi.2012.66] [Cited by in Crossref: 126] [Cited by in F6Publishing: 126] [Article Influence: 12.6] [Reference Citation Analysis]
154 Boddicker RL, Koltes JE, Fritz‐waters ER, Koesterke L, Weeks N, Yin T, Mani V, Nettleton D, Reecy JM, Baumgard LH, Spencer JD, Gabler NK, Ross JW. Genome‐wide methylation profile following prenatal and postnatal dietary omega‐3 fatty acid supplementation in pigs. Anim Genet 2016;47:658-71. [DOI: 10.1111/age.12468] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
155 Pineda-peña EA, Jiménez-andrade JM, Castañeda-hernández G, Chávez-piña AE. Docosahexaenoic acid, an omega-3 polyunsaturated acid protects against indomethacin-induced gastric injury. European Journal of Pharmacology 2012;697:139-43. [DOI: 10.1016/j.ejphar.2012.09.049] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
156 Tang H, Liu Y, Yan C, Petasis NA, Serhan CN, Gao H. Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury. J Immunol 2014;193:3769-78. [PMID: 25172497 DOI: 10.4049/jimmunol.1400942] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
157 Ahluwalia K, Ebright B, Chow K, Dave P, Mead A, Poblete R, Louie SG, Asante I. Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development. Metabolites 2022;12:333. [DOI: 10.3390/metabo12040333] [Reference Citation Analysis]
158 Lim JY, Park CK, Hwang SW. Biological Roles of Resolvins and Related Substances in the Resolution of Pain. Biomed Res Int 2015;2015:830930. [PMID: 26339646 DOI: 10.1155/2015/830930] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
159 Wang RX, Colgan SP. Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses. Mol Aspects Med 2017;58:93-101. [PMID: 28232096 DOI: 10.1016/j.mam.2017.02.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
160 Mas E, Croft KD, Zahra P, Barden A, Mori TA. Resolvins D1, D2, and Other Mediators of Self-Limited Resolution of Inflammation in Human Blood following n-3 Fatty Acid Supplementation. Clinical Chemistry 2012;58:1476-84. [DOI: 10.1373/clinchem.2012.190199] [Cited by in Crossref: 180] [Cited by in F6Publishing: 171] [Article Influence: 18.0] [Reference Citation Analysis]
161 Liao Z, Dong J, Wu W, Yang T, Wang T, Guo L, Chen L, Xu D, Wen F. Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. Respir Res 2012;13:110. [PMID: 23199346 DOI: 10.1186/1465-9921-13-110] [Cited by in Crossref: 101] [Cited by in F6Publishing: 104] [Article Influence: 10.1] [Reference Citation Analysis]
162 Chen J, Shetty S, Zhang P, Gao R, Hu Y, Wang S, Li Z, Fu J. Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury. Toxicology and Applied Pharmacology 2014;277:118-23. [DOI: 10.1016/j.taap.2014.03.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
163 Pineda-peña EA, Martínez-pérez Y, Galicia-moreno M, Navarrete A, Segovia J, Muriel P, Favari L, Castañeda-hernández G, Chávez-piña AE. Participation of the anti-inflammatory and antioxidative activity of docosahexaenoic acid on indomethacin-induced gastric injury model. European Journal of Pharmacology 2018;818:585-92. [DOI: 10.1016/j.ejphar.2017.11.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
164 Mustafa M, Zarrough A, Bolstad AI, Lygre H, Mustafa K, Hasturk H, Serhan C, Kantarci A, Van Dyke TE. Resolvin D1 protects periodontal ligament. Am J Physiol Cell Physiol 2013;305:C673-9. [PMID: 23864609 DOI: 10.1152/ajpcell.00242.2012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
165 Caprara G, Allavena P, Erreni M. Intestinal Macrophages at the Crossroad between Diet, Inflammation, and Cancer. Int J Mol Sci 2020;21:E4825. [PMID: 32650452 DOI: 10.3390/ijms21144825] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
166 Klein CP, Sperotto ND, Maciel IS, Leite CE, Souza AH, Campos MM. Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice. Neuropharmacology 2014;86:57-66. [DOI: 10.1016/j.neuropharm.2014.05.043] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 6.5] [Reference Citation Analysis]
167 Hu X, Shen H, Wang Y, Zhang L, Zhao M. Aspirin-triggered resolvin D1 alleviates paraquat-induced acute lung injury in mice. Life Sciences 2019;218:38-46. [DOI: 10.1016/j.lfs.2018.12.028] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
168 Tian R, Zuo X, Jaoude J, Mao F, Colby J, Shureiqi I. ALOX15 as a suppressor of inflammation and cancer: Lost in the link. Prostaglandins Other Lipid Mediat 2017;132:77-83. [PMID: 28089732 DOI: 10.1016/j.prostaglandins.2017.01.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
169 Barden A, Mas E, Croft KD, Phillips M, Mori TA. Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation. J Lipid Res 2014;55:2401-7. [PMID: 25187667 DOI: 10.1194/jlr.M045583] [Cited by in Crossref: 60] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
170 Leuti A, Fazio D, Fava M, Piccoli A, Oddi S, Maccarrone M. Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev 2020;159:133-69. [PMID: 32628989 DOI: 10.1016/j.addr.2020.06.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
171 Hsiao H, Sapinoro RE, Thatcher TH, Croasdell A, Levy EP, Fulton RA, Olsen KC, Pollock SJ, Serhan CN, Phipps RP, Sime PJ, Yildirim AÖ. A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung Inflammation. PLoS ONE 2013;8:e58258. [DOI: 10.1371/journal.pone.0058258] [Cited by in Crossref: 121] [Cited by in F6Publishing: 119] [Article Influence: 13.4] [Reference Citation Analysis]
172 Weiss GA, Troxler H, Klinke G, Rogler D, Braegger C, Hersberger M. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis 2013;12:89. [PMID: 23767972 DOI: 10.1186/1476-511X-12-89] [Cited by in Crossref: 91] [Cited by in F6Publishing: 53] [Article Influence: 10.1] [Reference Citation Analysis]
173 Köhnke T, Gomolka B, Bilal S, Zhou X, Sun Y, Rothe M, Baumgart DC, Weylandt KH. Acetylsalicylic Acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators. Biomed Res Int. 2013;2013:748160. [PMID: 24083240 DOI: 10.1155/2013/748160] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
174 Bisicchia E, Sasso V, Molinari M, Viscomi MT. Plasticity of microglia in remote regions after focal brain injury. Semin Cell Dev Biol 2019;94:104-11. [PMID: 30703556 DOI: 10.1016/j.semcdb.2019.01.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
175 Zhao YL, Zhang L, Yang YY, Tang Y, Zhou JJ, Feng YY, Cui TL, Liu F, Fu P. Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis. Chin Med J (Engl) 2016;129:1100-7. [PMID: 27098797 DOI: 10.4103/0366-6999.180517] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]